Corcept Therapeutics | CORT - 贸易债权人



金融业
股票价格
USD
资产
USD 888.7M
现金及等价物
USD 111.04M
销售成本
USD 4.06M
流动资产
USD 439.68M
流动负债
USD 153.8M
债务
USD 9.64M
EBIT
USD 41.3M
EBITDA
USD -49M
员工
500
EPS每股收益
USD 0.36
股本和储备
USD 705.78M
销售毛利
USD 252.09M
债务利息支出
USD 888.7M
利息收入
USD 4.89M
市值
USD 11.92B
净收入
USD 42.14M
营业费用
USD 214.85M
营业利润
USD 41.3M
普通股股本
USD 107.33M
PE价格收益
188.23
税前利润
USD -44.72M
销售收入
USD 256.15M
销售和管理费用
USD 156.9M
股票
USD 13.19M
贸易债权人
USD 14.91M
应收帐款人
USD 76.92M


贸易债权人 更改 日
Acadia Pharmaceuticals USD 44.57M 32.32M 2026-06
Alaunos Therapeutics USD 400K 213K 2026-03
ANI Pharmaceuticals USD 73.83M 4.14M 2026-06
Ardelyx USD 28.2M 8.96M 2026-03
Aurora Cannabis CAD 9.31M 58.72M 2026-03
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Canopy Growth CAD 34.82M 14.85M 2026-03
Corcept Therapeutics USD 14.91M 18.4M 2026-06
Eli Lilly USD 6.11B 1.08B 2026-06
J&J USD 9.22B 1.24B 2026-06
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Lexicon Pharmaceuticals USD 3M 87K 2026-03
Merck USD 3.83B 36M 2026-06
Nektar Therapeutics USD 10.03M 744K 2026-03
Novartis USD 4.26B 64M 2026-06
Novartis USD 4.32B 134M 2026-03
Omeros USD 8.84M 4.42M 2025-06
Pacira USD 17.51M 3.5M 2026-06
Pfizer USD 4.58B 75M 2026-06
Supernus Pharmaceuticals USD 5.59M 4.58M 2026-06
TG Therapeutics USD 213.69M 64.85M 2026-06